COHR · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $5.81B | $4.71B | $5.16B | $3.32B | $3.11B | $2.38B | $1.36B | $1.16B |
| Cost of Revenue | $3.77B | $3.25B | $3.54B | $2.05B | $1.93B | $1.59B | $841.15M | $696.59M |
| Research & Development | $581.92M | $478.79M | $499.60M | $377.11M | $330.11M | $339.07M | $139.16M | $116.88M |
| Selling, General & Administrative | $926.45M | $854.00M | $1.04B | $474.10M | $445.24M | $412.63M | $233.52M | $208.56M |
| Operating Expenses | $5.72B | $4.86B | $5.52B | $3.03B | $2.75B | $2.44B | $1.23B | $1.04B |
| Operating Income | — | $96.12M | -$37.12M | $414.29M | $402.12M | $39.48M | $148.67M | $136.76M |
| Interest Expense | — | — | $286.87M | $121.25M | $59.90M | $89.41M | $22.42M | $18.35M |
| Income Before Taxes | $94.18M | -$147.65M | -$355.56M | $281.81M | $352.59M | -$63.93M | $128.81M | $122.19M |
| Provision for Income Taxes | $64.12M | $11.12M | -$96.10M | $47.05M | $55.04M | $3.10M | $21.30M | $34.19M |
| Net Income | $49.36M | -$156.15M | -$259.46M | $234.76M | $297.55M | -$67.03M | $107.52M | $88.00M |
| Basic EPS | -$0.52 | -$1.84 | -$2.93 | $1.57 | $2.50 | -$0.79 | $1.69 | $1.41 |
| Diluted EPS | -$0.52 | -$1.84 | -$2.93 | $1.45 | $2.37 | -$0.79 | $1.63 | $1.35 |
| Basic Shares Outstanding | — | 151.64M | 137.58M | 106.19M | 104.15M | 84.83M | 63.58M | 62.50M |
| Diluted Shares Outstanding | 154.75M | 151.64M | 137.58M | 116.51M | 115.03M | 84.83M | 65.80M | 65.13M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Jun 2026 | $4.70 | $4.63 | $4.79 | 9 | ↑2 ↓0 |
| Jun 2027 | $7.61 | $6.56 | $9.40 | 9 | ↑2 ↓1 |
| Jun 2028 | $11.20 | $10.97 | $11.43 | 2 | ↑2 ↓0 |